ArticleJournal of the National Cancer Institute2022
Deep Learning vs Traditional Breast Cancer Risk Models to Support Risk-Based Mammography Screening.
Article in Journal of the National Cancer Institute, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Current state of mammography-based artificial intelligence for future breast cancer risk prediction: a systematic review.Journal of the National Cancer Institute · 2026Pooled it
- Artificial Intelligence-Driven Mammography-Based Future Breast Cancer Risk Prediction: A Systematic Review.Journal of the American College of Radiology : JACR · 2024Pooled it
- From pixels to pathology: how artificial intelligence mammographic risk scores capture tumor biology through imaging.European radiology · 2026Article
- Performance of clinical breast cancer risk prediction models vs a mammography-based artificial intelligence risk model.Journal of the National Cancer Institute · 2026Article
- Cross-Device Adaptation of Mirai for Mammography-Based Breast Cancer Risk Prediction.medRxiv : the preprint server for health sciences · 2026Article
- Performance of an image-only deep learning breast cancer risk model with the addition of a polygenic risk score.British journal of cancer · 2026Article
- Generalizability of an AI-based mammogram risk score (MRS) for breast cancer among diverse populations of women.Science advances · 2026Article
- A Deep Learning Breast Cancer Risk Model for Precise Supplemental Screening.JAMA network open · 2026Article
- Deep learning for incidence rate prediction and radiation risk assessment of solid tumors.Scientific reports · 2026Article
- Performance of breast cancer risk prediction algorithms across mammography systems in the UK screening programme.NPJ digital medicine · 2026Article
- Deep transfer learning for breast cancer detection in underserved regions.Frontiers in oncology · 2026Article
- Predicting short- to long-term breast cancer risk from longitudinal mammographic screening history.NPJ breast cancer · 2025Article
- The Future of Breast Cancer Organized Screening Program Through Artificial Intelligence: A Scoping Review.Healthcare (Basel, Switzerland) · 2025Review
- Artificial intelligence integrates multi-omics data for precision stratification and drug resistance prediction in breast cancer.Frontiers in oncology · 2025Review
- Response to the New USPSTF Recommendations on Breast Cancer Screening: Shared Decision-Making is the Cornerstone of Person-Centered Care.Mayo Clinic proceedings · 2024Article
- Hybrid ensemble deep learning model for advancing breast cancer detection and classification in clinical applications.Heliyon · 2024Article
- Artificial intelligence to unlock real-world evidence in clinical oncology: A primer on recent advances.Cancer medicine · 2024Review
- Patterns and Predictors of Referral for Screening Breast MRI: A Mixed-Methods Study.Journal of women's health (2002) · 2024Article
- External Evaluation of a Mammography-based Deep Learning Model for Predicting Breast Cancer in an Ethnically Diverse Population.Radiology. Artificial intelligence · 2023Article
- Identifying Effective Biomarkers for Accurate Pancreatic Cancer Prognosis Using Statistical Machine Learning.Diagnostics (Basel, Switzerland) · 2023Article
Corrections and comments
- Commented on by
- Commented on byBeyond the2023
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDeep learning breast cancer risk models demonstrate improved accuracy compared with traditional risk models but have not been prospectively tested. We compared the accuracy of a deep learning risk score derived from the patient's prior mammogram to traditional risk scores to prospectively identify patients with cancer in a cohort due for screening.
methodsWe collected data on 119 139 bilateral screening mammograms in 57 617 consecutive patients screened at 5 facilities between September 18, 2017, and February 1, 2021. Patient demographics were retrieved from electronic medical records, cancer outcomes determined through regional tumor registry linkage, and comparisons made across risk models using Wilcoxon and Pearson χ2 2-sided tests. Deep learning, Tyrer-Cuzick, and National Cancer Institute Breast Cancer Risk Assessment Tool (NCI BCRAT) risk models were compared with respect to performance metrics and area under the receiver operating characteristic curves.
resultsCancers detected per thousand patients screened were higher in patients at increased risk by the deep learning model (8.6, 95% confidence interval [CI] = 7.9 to 9.4) compared with Tyrer-Cuzick (4.4, 95% CI = 3.9 to 4.9) and NCI BCRAT (3.8, 95% CI = 3.3 to 4.3) models (P < .001). Area under the receiver operating characteristic curves of the deep learning model (0.68, 95% CI = 0.66 to 0.70) was higher compared with Tyrer-Cuzick (0.57, 95% CI = 0.54 to 0.60) and NCI BCRAT (0.57, 95% CI = 0.54 to 0.60) models. Simulated screening of the top 50th percentile risk by the deep learning model captured statistically significantly more patients with cancer compared with Tyrer-Cuzick and NCI BCRAT models (P < .001).
conclusionsA deep learning model to assess breast cancer risk can support feasible and effective risk-based screening and is superior to traditional models to identify patients destined to develop cancer in large screening cohorts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.